ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.77
-1.09%
US Tech 100
20,778.00
-0.69%
S&P 500
6,040.53
-0.50%
US Dollar vs CAD
1.45405
0.00%
Bitcoin
102,346.48
-0.07%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. AstraZeneca PLC (AZN) Share Price

AstraZeneca PLC

AstraZeneca PLC (AZN)

Astrazeneca Plc
AstraZeneca PLC
AZN Capital Corp
54.17
0.00
(0.00%)
Closed February 01 3:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
54.17
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
83.972B
Previous Close
54.17
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
1,550,163,000
Dividend Yield
-
PE Ratio
29.64
Earnings Per Share (EPS)
3.84
Revenue
45.81B
Net Profit
5.96B

About AstraZeneca PLC

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from intern... A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its revenue. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.astrazeneca.com
Headquarters
Cambridge, Gbr
Founded
-

Ask ADVFN Intelligence (AI)

AZN Latest News

More News

Targeting Cancer's Achilles Heel: AI-Driven DDR Therapies Offer Hope

Cancer, a complex disease characterized by uncontrolled cell growth and proliferation, is often rooted in defects within DNA repair mechanisms. Normally, cells possess intricate To read the full...

September 17 2024
AllPennyStocks.com

Biotech Shares Soar After AstraZeneca Stake & Research Collaboration

A Paris-based healthcare company saw an insanely bullish session on Wednesday after it was announced that AstraZeneca

November 01 2023
AllPennyStocks.com

EVUSHELD™  significantly protected against symptomatic COVID-19 for at least six months in PROVENT Phase III trial in high-risk populations

Pre-exposure prophylaxis (prevention) trial reduced risk of symptomatic COVID-19, with no severe disease or COVID-19-related deaths in EVUSHELD group Data published in the New England Journal of...

April 20 2022
Business Wire

ULTOMIRIS® (ravulizumab-cwvz) demonstrated sustained improvements in functional activities and quality of life in adults with generalized myasthenia gravis through 60 weeks

Analysis of Phase III CHAMPION-MG trial open-label extension adds to growing body of safety and efficacy data for ULTOMIRIS in generalized myasthenia gravis Patients who transitioned from...

April 06 2022
Business Wire

AstraZeneca Announces New Partnership with The National Fish and Wildlife Foundation to Plant One Million Trees

Partnership contributes to the AZ Forest global initiative to plant and maintain 50 million trees worldwide by the end of 2025 AstraZeneca has partnered with The National Fish and Wildlife...

March 24 2022
Business Wire

EVUSHELD™ long-acting antibody combination retains neutralizing activity against Omicron variants including BA.2 in new independent studies

First in vivo data from Washington University show EVUSHELD reduces viral burden of all tested Omicron subvariants in the lungs New preclinical authentic ‘live’ virus data from Washington...

March 21 2022
Business Wire

ENHERTU® (fam-trastuzumab deruxtecan-nxki) Significantly Improved Both Progression-Free and Overall Survival in DESTINY-Breast04 Trial in Patients with HER2-Low Metastatic Breast Cancer

First HER2-low metastatic breast cancer Phase III results for AstraZeneca and Daiichi Sankyo’s ENHERTU offer potential to redefine how the disease is classified and treated Positive high-level...

February 21 2022
Business Wire

LYNPARZA® (olaparib) plus Abiraterone Reduced Risk of Disease Progression by 34% vs. Standard-of-Care in 1st-Line Metastatic Castration-Resistant Prostate Cancer

Combination was well tolerated and allowed patients to maintain their quality of life vs. patients treated with abiraterone alone PROpel Phase III trial results show clinically meaningful...

February 14 2022
Business Wire

Eplontersen granted Orphan Drug Designation in the US for transthyretin amyloidosis

Eplontersen has been granted Orphan Drug Designation (ODD) in the US by the Food and Drug Administration (FDA) for the treatment of transthyretin-mediated amyloidosis, a systemic, progressive and...

January 24 2022
Business Wire

IMFINZI® (durvalumab) Plus Tremelimumab Demonstrated Unprecedented Survival in 1st-line Unresectable Liver Cancer With 31% of Patients Alive at Three Years

A single priming dose of tremelimumab plus IMFINZI every four weeks reduced risk of death by 22% in HIMALAYA Phase III trial Combination also showed no increase in severe liver toxicity and...

January 18 2022
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

AZN - Frequently Asked Questions (FAQ)

What is the current AstraZeneca share price?
The current share price of AstraZeneca is US$ 54.17
How many AstraZeneca shares are in issue?
AstraZeneca has 1,550,163,000 shares in issue
What is the market cap of AstraZeneca?
The market capitalisation of AstraZeneca is USD 83.97B
What is the 1 year trading range for AstraZeneca share price?
AstraZeneca has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of AstraZeneca?
The price to earnings ratio of AstraZeneca is 29.64
What is the cash to sales ratio of AstraZeneca?
The cash to sales ratio of AstraZeneca is 3.85
What is the reporting currency for AstraZeneca?
AstraZeneca reports financial results in USD
What is the latest annual turnover for AstraZeneca?
The latest annual turnover of AstraZeneca is USD 45.81B
What is the latest annual profit for AstraZeneca?
The latest annual profit of AstraZeneca is USD 5.96B
What is the registered address of AstraZeneca?
The registered address for AstraZeneca is 1 FRANCIS CRICK AVENUE, CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE, CB2 0AA
What is the AstraZeneca website address?
The website address for AstraZeneca is www.astrazeneca.com
Which industry sector does AstraZeneca operate in?
AstraZeneca operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MBIMBIA Inc
US$ 7.11
(15.42%)
2.37M
ALURAllurion Technologies Inc
US$ 6.07
(13.46%)
571.74k
SESSES AI Corporation
US$ 1.19
(13.33%)
24.78M
ENFYEnlightify Inc
US$ 1.36
(12.40%)
95.69k
LITBLightInTheBox Holding Co Ltd
US$ 1.155
(12.14%)
17.51k
DECKDeckers Outdoor
US$ 177.46
(-20.46%)
15.04M
BZHBeazer Homes USA Inc New
US$ 22.18
(-19.93%)
2.11M
VSTSVestis Corporation
US$ 14.00
(-11.62%)
6.16M
KOREKORE Group Holdings Inc
US$ 2.29
(-9.13%)
36.39k
NOVASunnova Energy International Inc
US$ 2.565
(-9.04%)
14.63M
FFord Motor Company
US$ 10.08
(-0.79%)
103.95M
QBTSD Wave Quantum Inc
US$ 5.94
(5.32%)
74.97M
BBDBanco Bradesco SA
US$ 2.12
(0.47%)
55.74M
NUNu Holdings Ltd
US$ 13.25
(-1.41%)
47.85M
VZVerizon Communications Inc
US$ 39.39
(-0.20%)
44.69M

Discussion

View Full Feed
LuckyPanda LuckyPanda 5 minutes ago
I'm 100% positive money is coming to old escrow owners...Why else would the FDIC go through so much trouble to not close the receivership after 16 years?? However I'm not sure if I will ever see this money. I'm now 48 and I have a feeling I will retire before the receivership closes. Maybe my son w
COOP
lovethatgreen lovethatgreen 14 minutes ago
Myself as well but at 32

Small OS atm
DanM51 DanM51 14 minutes ago
"Maybe you should join me in a squirrel suit"....I think we all suspected Spartex was a Furry.🦫🐿
LWLG
raggi65 raggi65 15 minutes ago
Dragoon, some clocks tick differently; only in 2040 will Lodas be eligible for a midlife crisis and Jamie get his wisdom teeth.
But in 2040, science will be so advanced that the most important figures in human history, namely Lenin, Kissinger and Lord Rothschild, can be brought back to life
COOP
trader53 trader53 22 minutes ago
DPLS 0.00055 - ALERTING STRONG BUY!


DPLS 0.0005 "Trader53 is In Bound"
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175742360

DPLS 0.0005 "Trader53 Ain’t Worried"
https://investorshub.advfn.com/boards/read_msg.aspx?message_id
DPLS MFI
Hawk05 Hawk05 23 minutes ago
https://www.actipatch.nz/?
BIEL
trader53 trader53 23 minutes ago
DPLS 0.00055 - ALERTING STRONG BUY!


DPLS 0.0005 "Trader53 is In Bound"
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175742360

DPLS 0.0005 "Trader53 Ain’t Worried"
https://investorshub.advfn.com/boards/read_msg.aspx?message_id
DPLS MFI
TommyJ7651 TommyJ7651 37 minutes ago
I really don't think his aim is to keep this sanctions going. It's sort of a "mafia tactic" in the sense that he throws out these threats and expects countries to come back begging for his mercy and do his bidding. The only problem this time around is that countries are far more resistant to his pol
FFMGF
jeunke22 jeunke22 38 minutes ago
https://investorshangout.com/lightwave-logics-participation-in-spie-photonics-west-event-196196-/
LWLG
BDEZ BDEZ 42 minutes ago
FL Legislature secretly trying to stop mass deportations

CORRUPTION 🚨 Florida Legislature secretly trying to stop mass deportations

“The bill the legislature sent me — in the bill, they prohibit our state agencies and your local agencies from even talking to ICE
STL Stock STL Stock 42 minutes ago
Polaroids were an obvious scam by Edwin H. Land. A device that takes a picture and develops the film and spits it out of the camera? Really? Unpossible! Clearly wizardry designed to lure marks. Developing film instantly is very scammy and fraudy.

I wanted to beat the usual suspects t
HMBL
1hunglo 1hunglo 43 minutes ago
SLO MO NO GO KORENKO TO THE RESCUE LOL
RDGL
joeycav11 joeycav11 48 minutes ago
Baxers thanks for that real word story from your heart…Your memory recall of the time shows the stress you were experiencing.
Your contributions to this board have been appreciated.
Iam also someone that looked for cancer vaccines as an alternative treatment. That was 15 years ago.
NWBO
Researchfyi Researchfyi 49 minutes ago
“Instead of trying to "build it back better", how about "Put it back the way you found it"

Source: Watts Watt.

I think that is what is happening now.
LQMT
Genz2 Genz2 49 minutes ago
Methinks, and then there is Robert Frankenberg, on Wave Board of Directors who is a computer engineer who went to Stanford!! I received my degree in Economics and don’t have education in engineering, but I’m smart enough to recognize all the smart guys behind Wave!!! Now if only our country was li
gdl gdl 55 minutes ago
I seem to be living in a vacuum or the twilight zone. I shouted, stomped my feet declaring a crash was coming and everyone told me relax the street concluded the Pandemic was no big deal. I predicted EXACTLY what Trump would do on day one. I know with certainty how this end. Like the Pandemic we h
SPY
fuagf fuagf 59 minutes ago
B402, As non-responsive as you are fake in your independent claim. Imagine having to claim independence to help youself feel worthy, and a fraudulent claim at that. Can only imagine the feeling, you would know. Oh, was waiting for your reply to,

[...] Be specific. What exactly in j
littlejohn littlejohn 1 hour ago
So, doesn't ollama which is used to down

load deepseek offer security protection?...

Not referring to any potential data mining

that the site might be capable of..

Users would have to use more sophisticated

llamma versions to
SMCI
Sammy boy Sammy boy 1 hour ago
Navy you’re the Best ! It was very disappointing reading the AH’s post. I wish it was directed at me, thanks for your service!
FNMA
BDEZ BDEZ 1 hour ago
AZ $339M unaccounted for in the state budget. This comes hot on the heels of Governor Hobbs' budget director's abrupt resignation. Questions abound on the financial oversight and transparency

https://x.com/catturd2/status/1885352062369530217
BDEZ BDEZ 1 hour ago
47 says he will put tariffs on oil and gas by Feb 18
BDEZ BDEZ 1 hour ago
47 says he will put tariffs on oil and gas by Feb 18
jhdf51 jhdf51 1 hour ago
Nothing matters until it matters.

JHD
COOP
BDEZ BDEZ 1 hour ago
Pres. of Panama says that there will be no negotiations for the U.S. taking back the Panama Canal, per the Guardian

Your Recent History

NYSE
AZN
AstraZeneca
UNSW
RSRETH
Reserve Rights
COIN
RIKEUR
BIT
CPR
Davide Campari
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads